Literature DB >> 11017919

Effect of cigarette smoke on the permeability and IL-1beta and sICAM-1 release from cultured human bronchial epithelial cells of never-smokers, smokers, and patients with chronic obstructive pulmonary disease.

C Rusznak1, P R Mills, J L Devalia, R J Sapsford, R J Davies, S Lozewicz.   

Abstract

Although cigarette smoking is of paramount importance in the development of chronic obstructive pulmonary disease (COPD), only a small proportion of smokers develop the disease. We tested the hypothesis that the response of the bronchial epithelium to cigarette smoke (CS) differs in patients with COPD. Such a difference might explain in part why only some cigarette smokers develop the disease. We established primary explant cultures of human bronchial epithelial cells (HBEC) from biopsy material obtained from never-smokers who had normal pulmonary function, smokers with normal pulmonary function, and smokers with COPD, and exposed these for 20 min to CS or air. Measurements were subsequently made over a period of 24 h of transepithelial permeability and release of interleukin (IL)-1beta and soluble intercellular adhesion molecule-1 (sICAM-1). In addition, intracellular reduced glutathione (GSH) levels were measured after 24 h incubation. Exposure to CS increased the permeability of these cultures in all study groups, but the most marked effect was observed in cultures from patients with COPD (mean increase, 85.5%). The smallest CS-induced increase in the permeability was observed in HBEC cultured from smokers with normal pulmonary function (mean, 25.0%), and this was significantly lower than that of HBEC from never-smokers (mean, 53.4%) (P<0.001). Compared with exposure to air, exposure to CS led to a significantly increased release of these mediators from cultures of the never-smoker group (mean 250.0% increase in IL-1beta and mean 175.3% increase in sICAM-1 24 h after exposure) and COPD group (mean 383.3% increase in IL-1beta and mean 97.4% increase in sICAM-1 24 h after exposure). In contrast, CS exposure did not influence significantly the release of either mediator from the cells of smokers with normal pulmonary function. Levels of intracellular GSH were significantly higher in cultures of HBEC derived from smokers, both those with normal pulmonary function and those with COPD, compared with cultures from healthy never-smokers. Exposure to CS significantly decreased the concentration of intracellular GSH in all cultures. However, the fall in intracellular GSH was significantly greater in cells from patients with COPD (mean 72.9% decrease) than in cells from never-smokers (mean 61.4% decrease; P = 0.048) or smokers with normal pulmonary function (mean 43.9% decrease; P = 0.02). These results suggest that whereas smokers with or without COPD demonstrate increased levels of GSH within bronchial epithelial cell cultures, those with COPD have a greater susceptibility to the effects of CS in reducing GSH levels and causing increased permeability and release of proinflammatory mediators such as IL-1beta and sICAM-1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11017919     DOI: 10.1165/ajrcmb.23.4.3959

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  49 in total

Review 1.  Acute effects of cigarette smoke on inflammation and oxidative stress: a review.

Authors:  H van der Vaart; D S Postma; W Timens; N H T ten Hacken
Journal:  Thorax       Date:  2004-08       Impact factor: 9.139

2.  ICAM-1, ICAM-2 and ICAM-3 in the sera of patients with idiopathic pulmonary fibrosis.

Authors:  Pelagia G Tsoutsou; Konstantinos I Gourgoulianis; Efthymia Petinaki; Maria Mpaka; Smaragda Efremidou; Antonios Maniatis; Pashalis Adam Molyvdas
Journal:  Inflammation       Date:  2004-12       Impact factor: 4.092

Review 3.  Molecular processes that drive cigarette smoke-induced epithelial cell fate of the lung.

Authors:  Toru Nyunoya; Yohannes Mebratu; Amelia Contreras; Monica Delgado; Hitendra S Chand; Yohannes Tesfaigzi
Journal:  Am J Respir Cell Mol Biol       Date:  2014-03       Impact factor: 6.914

4.  Impact of acute exposure to cigarette smoke on airway gene expression.

Authors:  E Billatos; A Faiz; Y Gesthalter; A LeClerc; Y O Alekseyev; X Xiao; G Liu; N H T Ten Hacken; I H Heijink; W Timens; C A Brandsma; D S Postma; M van den Berge; A Spira; M E Lenburg
Journal:  Physiol Genomics       Date:  2018-06-22       Impact factor: 3.107

Review 5.  Cells and Culture Systems Used to Model the Small Airway Epithelium.

Authors:  Rudra Bhowmick; Heather Gappa-Fahlenkamp
Journal:  Lung       Date:  2016-04-12       Impact factor: 2.584

6.  Reversal of cigarette smoke extract-induced sinonasal epithelial cell barrier dysfunction through Nrf2 Activation.

Authors:  Anuj Tharakan; Ashleigh A Halderman; Andrew P Lane; Shyam Biswal; Murugappan Ramanathan
Journal:  Int Forum Allergy Rhinol       Date:  2016-08-31       Impact factor: 3.858

7.  Soluble polysialylated NCAM: a novel player of the innate immune system in the lung.

Authors:  Christina Ulm; Mona Saffarzadeh; Poornima Mahavadi; Sandra Müller; Gerlinde Prem; Farhan Saboor; Peter Simon; Ralf Middendorff; Hildegard Geyer; Ingrid Henneke; Nils Bayer; Susanne Rinné; Thomas Lütteke; Eva Böttcher-Friebertshäuser; Rita Gerardy-Schahn; David Schwarzer; Martina Mühlenhoff; Klaus T Preissner; Andreas Günther; Rudolf Geyer; Sebastian P Galuska
Journal:  Cell Mol Life Sci       Date:  2013-04-26       Impact factor: 9.261

8.  Hyaluronan and layilin mediate loss of airway epithelial barrier function induced by cigarette smoke by decreasing E-cadherin.

Authors:  Rosanna Malbran Forteza; S Marina Casalino-Matsuda; Nieves S Falcon; Monica Valencia Gattas; Maria E Monzon
Journal:  J Biol Chem       Date:  2012-10-09       Impact factor: 5.157

Review 9.  Inflammatory response of lung macrophages and epithelial cells to tobacco smoke: a literature review of ex vivo investigations.

Authors:  Lauren A Smith; Geraldine M Paszkiewicz; Alan D Hutson; John L Pauly
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

Review 10.  Targeted treatment in COPD: a multi-system approach for a multi-system disease.

Authors:  David Anderson; William Macnee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.